Letrobol 2.5 (Letrozole USP 2.5mg) is an oral aromatase inhibitor. It works by significantly decreasing estrogen production in the body. Primarily prescribed as a breast cancer treatment, it is also utilized off-label to stimulate ovulation.
Semasize 1 mg Injection is a prescription medication used for managing type 2 diabetes, obesity, and reducing cardiovascular risks. It is a GLP-1 receptor agonist that acts as a weekly injection, often marketed as a pre-filled, multi-dose disposable pen.
| Strength | 1 mg |
| Main Ingredients | Semaglutide (0.5 mg, often paired with 0.25 mg in a titration pen). |
| Administration | Once-Weekly Subcutaneous Injection. |
| Storage | 2–8°C (Refrigerated) |
| Product Type | Multi-dose Disposable Pen (Pre-filled Syringe/PFS) |
| Type | GLP-1 receptor agonist |